https://www.selleckchem.com/products/vcmmae.html
68). IRM at 30 days was 5%, without differences by donor type (P = .106). Overall, 208 patients experienced ≥1 VIs (first occurrence among CMV, HHV6, ADV, BKPyV-HC) at a median time of 20 days after HSCT CIF at 90 days was 91%, significantly higher in MUD and haplo (P = .0089). By multivariate analysis, also acute GVHD grade ≥2 (AHR = 1.32) and host/donor CMV-serology mismatch (positive/positive versus negative/negative AHR = 2.95, positive/negative versus negative/negative AHR = 2.41, negative/positive versus negative/negative AHR = 2.3
Like
Comment
Share
